Company: GHRS
Filing Date: 2025-07-29
Form Type: 20-F/A
Source: 0001140361-25-027850
Chunk: 281

Company: GH Research PLC
Filing Date: 2025-07-29
Form: 20-F/A
Chunk 281
---
S 2. As such, the Company records a charge for the vested portion of award grants and for partially earned but non-vested portion of award grants . F-16 Table of Contents During the year ended December 31, 2024, the Company granted the option to purchase 1,320,120ordinary shares (2023: 440,719shares, 2022: 304,409shares), respectively, which were in line with the general terms of the Share Option Plan. The terms of the 1,320,120share options granted during the year ended December 31, 2024, are described below:

| • | 187,000share options were granted                                                                                                                                                                                                               
 which vest25% on the first anniversary of the date of grant, and thereafter evenly on a monthly basis over the                                                                                                                                  
 subsequentthree yearsand are subject to atwo-yearservice condition. The contractual term (expiration) of these share options iseight yearsfrom the grant date with an exercise price of the closing market price on the day prior to the grant. |

| • | 33,120share options were granted                                                                       
 which vested on the date of grant and are subject to atwo-yearservice condition. The contractual term  
 (expiration) of these share options isseven yearsfrom the grant date with an exercise price of $0.025. |

| • | 1,100,000share options were                                                                                                                                 
 granted which vest25% on the first anniversary of the date of grant, and thereafter evenly on a monthly basis                                               
 over the subsequentthree years. The contractual term (expiration) of these share options isseven yearsfrom the grant date with an exercise price of $0.025. |

During the year ended December 31, 2024, 241,293share options (2023: 104,299share options, 2022: nil) were forfeited. Noshare options were exercised during the year ended December 31, 2024. During the year ended December 31, 2023, the weighted average share price of share options exercised was $ 9.90.

The following table summarizes the share option awards outstanding as of December 31, 2024, 2023 and 2022:

|                        |     | Average        
 exercise price 
 per share in   
 USD            |       |     | Number of 
 awards    |           |   |     | Weighted          
 average           
 remaining life in 
 years             |      |
| At December